Prescribing policies on products for which there is no national direction are decided at local level, based on available clinical evidence and cost-effectiveness relative to other products.

PSWT with ActiPatch appears to be a safe and reasonably effective modality for treating certain types of chronic pain. There are no absolute contraindications to its use and can be safely used with any ongoing pain medication. The device does not lead to adverse effects, which is encountered with pharmacotherapy. Further studies might explore its role in managing chronic pain syndromes of varying etiology and would enlighten clinicians with its safety and efficacy.Financial support and sponsorship Actipatch is a therapy device which can help you to manage pain in your muscles and joints. It’s completely medication-free, working wherever you place it on the body to ease pain and inflammation without creating any uncomfortable heat or vibrations. If you suffer from chronic pain and are looking for long-term relief, ActiPatch could be the perfect solution for you. An spokesperson said: “Ultimately these are decisions for local GPs who rightly advise patients on their care, and have to decide how best to balance the various competing demands on the NHS.” ActiPatch works by sending out electromagnetic signal pulses into the area where you experience pain. It sends out 1,000 pulses every second, stimulating the neuromodulation of your nerves dampening the feeling of pain with every pulse. It does all this without creating any feeling of vibration, heat, or any other uncomfortable sensation which you may experience with other drug-free pain relief. NHS England said it was unable to comment on individual prescriptions but although Actipatch is available for prescription through the national drug tariff, products have not been subject to a technology appraisal by NICE.

Background

Read more at http://www.bielcorp.com/bioelectronics-wins-high-commendation-most-innovative-otc-product-award-otc-bulletin/ ActiPatch® Pain Relief Therapy Featured on Leading Healthcare Show in Spain Last month, the Royal College of General Practitioners announced that GPs did not want to prescribe them for long-term use. The complete details on the award winners are available in the 2013 OTC Awards Supplement http://www.otc-bulletin.com/awards/pdfs/WinnersSupplement2013.pdf. ActiPatch Canada Commercial Chronic pain syndrome is a difficult entity to manage for clinicians.[ 1] The management is multimodal that comprises pharmacological approach in the form of opioids, nonsteroidal anti-inflammatory drugs, gabapentinoids, antidepressants, antiepileptic agents, and a lot of other nonopioid medications. The patients are also advised nonpharmacological therapies such as physiotherapy sessions, acupressure, acupuncture, aromatherapy, and TENS. I do not want to return to higher levels of medication. And I’m still trying to wean myself off of the remaining prescribed medications too.”

Using ActiPatch could not be simpler, just position the device loop wherever you experience pain, ensuring that the area where you feel pain is positioned inside the loop. Fix the loop in place using plasters, bandages, clothing, wraps, or whichever method feels most comfortable. Turn the device on and leave it in place until your pain diminishes, it will continue to work for as long as you leave it switched on. If the device is on, you’ll notice a green light. If you’re using one of the 720-hour versions of this product, you can use the on/off switch when you remove your ActiPatch, saving energy when it’s not in use. ActiPatch is free from medication or hormones, and therefore should be fine to use at the same time as your medication. However, if you’re unsure you should always speak to your doctor or Chemist 4 U pharmacist before using this product, as they will help you to be sure thisWhen recommending or handing over care, specialists should ask primary care prescribers to take over prescribing responsibility, and should give enough information about the indication, dose, monitoring requirements, use outside product licence and any necessary dose adjustments to allow them to confidently prescribe. As a retired person, I can’t afford to keep shelling out this kind of money. We shouldn’t have to pay when it is available to be prescribed. If you’re new to Actipatch and aren’t sure which version of this product is the best for you, there are 4 options you can choose from. Each one works in the same way, but maybe easier to use on different areas of the body: This product is free from medication and is completely safe for use by people who have diabetes. It can also be used by those who suffer from other conditions, including people with arthritis, the elderly, and those who are bedridden. Primary care initiation or continuation of treatment is not recommended unless exceptional circumstances such as specialist GP.

ActiPatch Therapy is medical device that has been developed to treat pain and soft tissue injury. It is CE marked as a class II device, meaning that it has been cleared for sale in the European Union off the shelf, and it is commercially available in the UK. ActiPatch Therapy is simple to use and has no known side effects. The device consists of a control module and a loop antenna and is powered by a battery. ActiPatch is drug-free and therefore should not have any side effects when used as recommended by the manufacturer. However, if you do experience any side effects while using this product, you should speak to your doctor or Chemist 4 U pharmacist right away. For more information about reporting the side effects of treatments, please see the MHRA’s Yellow Card Scheme.

Indication

Primary care prescribers are advised not to take on prescribing of these medicines unless they have been adequately informed by letter of their responsibilities with regards monitoring, side effects and interactions and are happy to take on the prescribing responsibility. A copy of locally approved shared care guidelines should accompany this letter which outlines these responsibilities. Primary care prescribers should then tell secondary care of their intentions as soon as possible by letter so that arrangements can be made for the transfer of care. Primary care prescribers must be familiar with the drug to take on prescribing responsibility or must get the required information. Knee pain therapy device– This one comes with a reusable knee strap, which holds this product in place on your

It may not work in every single scenario, but medical professionals need to sit up and take notice of a risk-free treatment which could provide a drug-free alternative for thousands of people suffering through the agony of chronic pain.” And you only have to do some simple arithmetic to multiply the cost savings by the length of time a patient might be taking the drugs. The NHS has said it wants people off opioids, and you’ve only got to multiply that by 100, 1,000 or however many could be benefitting.”

Pharmacy product

ActiPatch currently hasn’t been clinically evaluated for use during pregnancy, so you should not use this product during this time. A panel of six independent over-the-counter marketing experts evaluated all twelve nominees from some of the world’s leading pharmaceutical companies. One of the judges, Jerome Reinsten, former Director-General of the World Self-Medication Industry, remarked that ActiPatch Therapy was a “novel and previously unexplored route to topical pain therapy,” while another judge felt the product range was an “ingenious way of providing pain relief.” He added: “Failure to get a grip of the amount of opioids we are prescribing could see the UK replicate the chronic addiction problems they are currently experiencing in the US.